Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.
about
SLC transporters as therapeutic targets: emerging opportunitiesSmall-molecule activator of glutamate transporter EAAT2 translation provides neuroprotectionAstrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytesMechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytesAstroglial cradle in the life of the synapse.Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's diseaseGenetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicityGlutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.Glutamatergic Mechanisms Associated with Seizures and Epilepsy.Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy.No preliminary evidence of differences in astrocyte density within the white matter of the dorsolateral prefrontal cortex in autism.Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.Metabolomics Based Identification of SIRT5 and Protein Kinase C Epsilon Regulated Pathways in Brain.Foreword: neurodegenerative diseases: challenges and opportunities.Quinolinic acid and glutamatergic neurodegeneration in Caenorhabditis elegans.Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets
P2860
Q27014726-0593D8B0-F917-4DFE-9527-8AEFB9486500Q30573062-BF8B9647-5B2B-4520-BDA6-EC11DE577D8DQ33693204-15C7017F-70FB-40FE-8BEC-DD8609451E2CQ33769843-2F743549-2ED3-4738-9FCC-8258BADBF0C8Q34236158-694F44DF-84B0-4CB9-9636-F0A0F426A6A8Q35161465-D237FE47-D3CC-485F-A676-10CE199E11F7Q38234167-F3B0E5FC-A3D4-4B82-B0E1-395709691999Q38512084-571F9EBC-AB1F-4A09-AC17-554B3EAB273DQ38535033-7B81D005-6C14-403D-8285-2669F20CF2FCQ42036618-C628EEB2-A755-41E6-857A-9EF0F9488C13Q42323492-862F0F8B-D8C6-4F3A-92DB-9379FB3D77EBQ47133260-CA8DDDE6-2AE7-40EE-AA38-AFEF2A736606Q48273821-EDE98C8B-3530-4D4B-8D6D-D04BE5DCD292Q50023937-53511B8A-D1A7-4A8E-AE76-AE142A060A23Q51563574-101D8025-26B4-4657-A846-56985E0F3617Q53400377-3E7E5683-26D1-4CF8-9283-F94BB6DD9B44Q57170405-F0E49FD1-0171-41EC-87DE-A6D2D0E337D5
P2860
Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@ast
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@en
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@nl
type
label
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@ast
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@en
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@nl
prefLabel
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@ast
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@en
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@nl
P2093
P2860
P356
P1476
Glutamate transporter EAAT2: a ...... of neurodegenerative diseases.
@en
P2093
Chien-Liang Glenn Lin
Gregory D Cuny
Marcie A Glicksman
Qiongman Kong
P2860
P304
P356
10.4155/FMC.12.122
P577
2012-09-01T00:00:00Z